Limited evidence on persistence with anticoagulants, and its effect on the risk of recurrence of venous thromboembolism: a systematic review of observational studies

References

• KearonCAklEAComerotaAJAntithrombotic therapy for vte disease: Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest20121412 supple419Se494S22315268
   PubMed Web of Science ®Google Scholar
• BeckmanMGHooperWCCritchleySEOrtelTLVenous thromboembolism: a public health concernAm J Prev Med2010384 SupplS495S50120331949
   PubMed Web of Science ®Google Scholar
• CohenATAgnelliGAndersonFAVenous thromboembolism (VTE) in Europe – The number of VTE events and associated morbidity and mortalityThromb Haemost2007981075676417938798
   PubMed Web of Science ®Google Scholar
• HeitJASilversteinMDMohrDNThe epidemiology of venous thromboembolism in the communityThromb Haemost200186745246311487036
   PubMed Web of Science ®Google Scholar
• BoutitieFPinedeLSchulmanSInfluence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: Analysis of individual participants’ data from seven trialsBMJ20113427810
   Google Scholar
• MiddeldorpSPrinsMHHuttenBADuration of treatment with vitamin K antagonists in symptomatic venous thromboembolismCochrane Database Syst Rev20148CD00136
   Web of Science ®Google Scholar
• KearonCGentMHirshJA comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolismN Engl J Med19993401290190710089183
   PubMed Web of Science ®Google Scholar
• HirschlMKundiMNew oral anticoagulants in the treatment of acute venous thromboembolism – a systematic review with indirect comparisonsVASA201443535336425147012
   PubMed Web of Science ®Google Scholar
• HeitJAMohrDNSilversteinMDPettersonTMO’FallonWMeltonLPredictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort studyArch Intern Med2000160676176810737275
   PubMed Web of Science ®Google Scholar
• CramerJARoyABurrellAMedication compliance and persistence: terminology and definitionsValue Health2008111444718237359
   PubMed Web of Science ®Google Scholar
• Cochrane-Bias-Methods-Group. Tool to Assess Risk of Bias in Cohort Studies2013 Available from: http://bmg.cochrane.org/sites/bmg.cochrane.org/files/uploads/Tool%20to%20Assess%20Risk%20of%20Bias%20in%20Cohort%20Studies.pdfAccessed July 2, 2014
   Google Scholar
• HowardLSHughesRJNICE guideline: management of venous thromboembolic diseases and role of thrombophilia testingThorax201368439139323234857
   PubMed Web of Science ®Google Scholar
• FreemanMFTukeyJWTransformations related to the angular and the square rootProject Euclid1950214607611
   Google Scholar
• DerSimonianRLairdNMeta-analysis in clinical trialsControlClin Trials198673177188
   PubMed Web of Science ®Google Scholar
• SchwarzerGMeta: meta-analysis with R. R package version2010215 Available from http://CRAN.R-project.org/package=meta
   Google Scholar
• ViechtbauerWConducting meta-analyses in R with the metafor packageJ Stat Softw2010363148
   Web of Science ®Google Scholar
• KaatzSFuACAbuDaggaADoes anticoagulant treatment duration vary by the risk of venous thromboembolism recurrence in clinical practice?J Thromb Haemost201311553554
   Web of Science ®Google Scholar
• LiuXXieLPhatakHPersistence on warfarin therapy in patients with venous thromboembolism: A large US insurance database analysisCirculation Epub 2013724
   Web of Science ®Google Scholar
• ChenSYWuNGulsethMOne-year adherence to warfarin treatment for venous thromboembolism in high-risk patients and its association with long-term risk of recurrent eventsJ Manag Care Pharm201319429130123627575
   PubMed Web of Science ®Google Scholar
• ReardonGPandyaNNutescuEAUse of warfarin therapy among residents who developed venous thromboembolism in the nursing homeAm J Geriatr Pharmacother201210636137223217529
   PubMedGoogle Scholar
• DeitelzweigSBLinJKreilickCHusseinMBattlemanDWarfarin therapy in patients with venous thromboembolism: Patterns of use and predictors of clinical outcomesAdv Ther201027962363320680533
   PubMed Web of Science ®Google Scholar
• KaatzSFuACAbuDaggaAAssociation between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practiceThromb Res2014134480781325127013
   PubMed Web of Science ®Google Scholar
• XieLLiuXPhatakHWarfarin discontinuation in patients with unprovoked venous thromboembolism: a large US insurance database analysisAm J Ther Epub2015724
   Web of Science ®Google Scholar
• TagalakisVPatenaudeVKahnSRSuissaSOral anticoagulation treatment and persistence after venous thromboembolism in a real world population: The Q-VTE study cohortBlood2013122212386
   Web of Science ®Google Scholar
• KöhlerCWerthSTittlLBeyer-WestendorfJAcute treatment of pulmonary embolism with rivaroxaban – Real life data from the prospective Dresden NOAC registry (NCT01588119)Blood201312221238023929856
   PubMed Web of Science ®Google Scholar
• CohenAMartinezCWallenhorstCBamberLVitamin K antagonist treatment patterns and persistence after venous thromboembolism in noncancer patients: VTE Epidemiology Group (VEG) StudyJ Thromb Haemost201311262723140188
   PubMed Web of Science ®Google Scholar
• Beyer-WestendorfJEbertzFGelbrichtVForsterKKohlerCWerthSTreatment of acute VTE with rivaroxaban. Updated results of the prospective Dresden NOAC registry (NCT01588119)J Thromb Haemost201311314315
   Web of Science ®Google Scholar
• Beyer-WestendorfJEbertzFForsterKChronic VTE treatment VTE with rivaroxaban. Updated results of the prospective Dresden NOAC registry (NCT01588119)J Thromb Haemost201311439
   Web of Science ®Google Scholar
• KoehlerCWerthSGelbrichtVReal life efficacy and safety of rivaroxaban for extended vte treatment-first results of the prospective NOAC registry (NCT01588119)Blood2012120212267
   Web of Science ®Google Scholar
• GelbrichtVKoehlerCWerthSReal life efficacy and safety of rivaroxaban for acute vte treatment-first results of the prospective NOAC registry (NCT01588119)Blood2012120211159
   Web of Science ®Google Scholar
• IorioAKearonCFilippucciERisk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: A systematic reviewArch Intern Med2010170191710171620975016
   PubMedGoogle Scholar
• MekajYHMekajAYDuciSBMiftariEINew oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic eventsTher Clin Risk Manag20151196797726150723
   PubMed Web of Science ®Google Scholar